Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial
Authors
Keywords
-
Journal
GUT
Volume -, Issue -, Pages gutjnl-2021-324060
Publisher
BMJ
Online
2021-05-13
DOI
10.1136/gutjnl-2021-324060
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
- (2021) Seung Tae Kim et al. Genome Medicine
- A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy
- (2020) Ziteng Li et al. EBioMedicine
- Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer
- (2019) R Sundar et al. ANNALS OF ONCOLOGY
- DNA methylation signature predictive of benefit from neoadjuvant chemotherapy in esophageal adenocarcinoma: Results from the MRC OEO2 phase III trial.
- (2019) Raghav Sundar et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Perioperative FLOT: new standard for gastric cancer?
- (2019) Yoon-Koo Kang et al. LANCET
- The Immunoscore: Colon Cancer and Beyond
- (2019) Helen K Angell et al. CLINICAL CANCER RESEARCH
- Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis
- (2018) Jae-Ho Cheong et al. LANCET ONCOLOGY
- Genomic Analyses and Precision Oncology in Gastroesophageal Cancer: Forwards or Backwards?
- (2018) Raghav Sundar et al. Cancer Discovery
- A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial).
- (2018) Yasuhiro Kodera et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013).
- (2018) Yasuhide Yamada et al. JOURNAL OF CLINICAL ONCOLOGY
- RAD9A promotes metastatic phenotypes through transcriptional regulation of Anterior Gradient 2 (AGR2)
- (2018) Constantinos G Broustas et al. CARCINOGENESIS
- A Deep Neural Network Model using Random Forest to Extract Feature Representation for Gene Expression Data Classification
- (2018) Yunchuan Kong et al. Scientific Reports
- Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma
- (2017) Aditi Qamra et al. Cancer Discovery
- FirebrowseR: an R client to the Broad Institute’s Firehose Pipeline
- (2017) Mario Deng et al. Database-The Journal of Biological Databases and Curation
- Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
- (2016) Yang Bai et al. Journal of Ovarian Research
- The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
- (2015) Waseem Ahmad Siddiqui et al. ARCHIVES OF TOXICOLOGY
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Second-line treatment of metastatic gastric cancer: Current options and future directions
- (2015) Dheepak Kanagavel WORLD JOURNAL OF GASTROENTEROLOGY
- Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
- (2014) E. Bajetta et al. ANNALS OF ONCOLOGY
- Robustness of Random Forest-based gene selection methods
- (2014) Miron Bartosz Kursa BMC BIOINFORMATICS
- Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial
- (2014) Akira Tsuburaya et al. LANCET ONCOLOGY
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
- (2013) James W. Hodge et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Integrated epigenomics identifiesBMP4as a modulator of cisplatin sensitivity in gastric cancer
- (2012) Tatiana Ivanova et al. GUT
- Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
- (2011) Iain Beehuat Tan et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started